| Tag | Content |
|---|
EnhancerAtlas ID | HS007-10775 |
Organism | Homo sapiens |
Tissue/cell | BE2C |
Coordinate | chr22:32072530-32073340 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF5 | MA0599.1 | chr22:32072862-32072872 | GCCCCGCCCC | + | 6.02 | | NFYA | MA0060.3 | chr22:32072885-32072896 | AGCCAATCAGA | + | 6.32 | | USF1 | MA0093.2 | chr22:32072777-32072788 | ACCACGTGACC | + | 6.32 | | USF2 | MA0526.2 | chr22:32072775-32072791 | TAACCACGTGACCCTC | - | 6.33 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_10007 | chr22:32072142-32073464 | CD14 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH22I031676 | chr22 | 32072188 | 32073393 |
|
Enhancer Sequence | GGAGTGCAGT GGCGCGACCT CGGCTCACGG CACCTACAGT CTCCCGAGTT CAAGCGATTC 60
TTCTGCCTCA GCTTCCCGAG TAGCTGGGAT TACAGGCGCG CGCCACCACT CCCGGCTAAT 120
TTTTTGTATT TTTAGTAGAG TCACCAGGTT GGCCAGGCCT GTCTCAAGTG ATCCGCCCGC 180
CTCTGCCTCC CAAAGTGCTG GGATTACAGG CTTGAGTCAC CGCGCCCGGC CCACGTGGCG 240
AGTCTTAACC ACGTGACCCT CCCCGCTCTC CAGCCCGGCA GGTACCAGCA AAGGACTAGC 300
AGCCTCCTCC AATATGGATA GCTTCTCGGA TGGCCCCGCC CCTCCGGAGA GCTGCAGCCA 360
ATCAGACGGC GTGAGGCCAG CAGTGGGTGC GGCTGCGCTT GGCGCTGCGC ATATCCGAAT 420
ACCAGGAAGT GCCCGGTTTC GCTGTCAGTG CTCGGGCAGC TAGAATCCAG GTCCCTTGAG 480
GAATAATTTA AGAAGGGGTG GAGAAAAATT AGGGGGCGTC TTCAAATATT CAGAGAGTCA 540
GCGAGGTAAA GAGGACTTGG GCAGGTCTGT GTAGCAACGG GGGCGGGAAT CATTCATTGA 600
CGCATGAAGT ATTTCCTGAG CTCCCACCAC GTAAGACCAA GTTTTGTTCT AGATGTCCGA 660
GGGGCCAGAG TGAATATAGC AAAGTCTTTG ACCTCAAGGA GCTTAACGTG AATAATATGG 720
GGACGTGGTG GTGTTAAAAA ATATATAAAA CAGGCCGGGT GCCGTGGCTC ACGCCTGTAA 780
TCCCAGCTCT TTGGGAGGCC AAGGCGGGTG 810
|
